Skip to main content
Fig. 10 | Journal of Translational Medicine

Fig. 10

From: Spatiotemporal evolution of AML immune microenvironment remodeling and RNF149-driven drug resistance through single-cell multidimensional analysis

Fig. 10

RNF149 Expression in AML Patient Tissues and Cell Lines. A Immunohistochemical analysis of RNF149 in bone marrow tissues from AML patients in chemotherapy remission and non-remission; B qRT-PCR assessment of RNF149 levels in AML cell lines compared to the normal control HS-5 cells; C Western blot quantification of RNF149 in MOLM13, MV4-11, MOLM13/R, and MV4-11/R cell lines

Back to article page